Private & Self-Pay Solutions

Oregon’s Drug Decriminalization Creates Unfunded Mandate for Treatment Providers

Oregon's November approval of Measure 110 decriminalizing drug possession represents a landmark shift in criminal justice and addiction policy, redirecting individuals caught with small amounts of controlled substances from...

Amid Growth, Pinnacle CEO Pushes for Methadone MAT Flexibilities

The past several months have been devastating for many behavioral health providers. The COVID-19 pandemic has caused widespread...

How the Pandemic Accelerated Telehealth Adoption

The coronavirus pandemic has reshaped the behavioral health landscape, creating both challenges and opportunities for mental health care...

Virtual Pediatric Behavioral Health Provider Brightline Raises $20 Million

Brightline, a Palo Alto-based startup specializing in virtual pediatric behavioral health care, recently announced a $20 million Series...

Discovery Behavioral Health Expands With Two New Adolescent Mental Health Centers

Discovery Behavioral Health, a portfolio company of Webster Equity Partners, has made another significant move in expanding its...
spot_img

The Promise and Pitfalls of Early Autism Prediction: What Parents Think

As scientific advancements continue to shape the future of healthcare, the possibility of early autism prediction in infants as young as six months old...

BeMe Health Raises $12.5 Million in Anticipation of Series A Round to Address Teen Mental Health Crisis

BeMe Health, a Miami-based digital health company focused on providing mental health support for teenagers, has announced it has raised $12.5 million in its...

Breaking Down Silos: The Future of Integrated Behavioral Health Services

For decades, behavioral health providers have operated in isolated silos, leaving patients to navigate a fragmented and often confusing system of care for substance...

Nearly a Quarter of U.S. Adults Received Mental Health Treatment in 2023: A Closer Look at the SAMHSA Report

In 2023, nearly a quarter of the adult population in the United States sought mental health treatment, according to the Substance Abuse and Mental...

FDA Rejects MDMA-Assisted Therapy for PTSD: What’s Next for Psychedelic Medicine?

After years of groundbreaking clinical trials and high expectations from both the medical and psychedelic research communities, Lykos Therapeutics has received a disappointing response...

Private Equity in Behavioral Health: Shifting Dynamics and Opportunities for 2024 and Beyond

As we enter the second half of 2024, there’s growing optimism in the private equity (PE) community regarding the future of healthcare investments. While...
spot_img